/PRNewswire/ The Leukemia & Lymphoma Society (LLS), the global leader and innovator in creating a world without blood cancer, is proud to announce E. Anders.
This randomized trial assesses whether metformin (vs placebo) given for 5 years would improve invasive disease–free survival and other outcomes in patients with
Plus: State to launch community-based mental health teams for kids Brooklyn-based maker of wearable neurostimulation device raises $2.5M Herald Square veterans' nonprofit to double services with $15M donation
A research team led by scientists at Albert Einstein College of Medicine has devised a novel and highly promising strategy for overcoming a key cause of cancer deaths: the ability of cancer cells to thrive in the face of chemotherapy drugs designed to destroy them.
In a new mouse study, scientists at Albert Einstein College of Medicine have developed a novel strategy for overcoming treatment-resistant cancer. Their findings provide insights into apoptotic resistance mechanisms and a potential novel therapeutic strategy that may help overcome apoptotic resistance in cancer.